当前位置:首页 - 行情中心 - 正海生物(300653) - 财务分析 - 利润表

正海生物

(300653)

57.59

-1.41  (-2.39%)

今开:58.50最高:58.95成交:0.82万手 市盈:0.00 上证指数:2780.96   -0.18%2018-08-14
昨收:59.00 最低:57.50 换手:0.00%振幅:0.00 深证指数:8784.90  -0.68%15:02:03

集合

竞价

利润表

按照会计年度查询:
报告期2018-06-302018-03-312017-12-312017-09-30
一、营业总收入105,197,363.7447,179,561.64182,782,114.4132,216,381.97
营业收入105,197,363.7447,179,561.64182,782,114.4132,216,381.97
二、营业总成本65,257,240.9425,428,114.29123,117,332.1189,992,775.75
营业成本7,951,246.923,442,338.4311,561,961.827,746,195.71
营业税金及附加944,603.86422,722.991,346,747.84988,922.32
销售费用39,812,235.2215,591,137.8776,303,290.9657,346,358.93
管理费用16,572,344.176,234,017.4835,893,892.3827,870,044.36
财务费用-450,578.97-230,441.67-2,128,496.78-4,196,858.23
资产减值损失427,389.74-31,660.81139,935.89238,112.66
三、其他经营收益--------
允许价值变动净收益--------
投资净收益6,470,463.783,666,202.726,199,926.79--
联营、合营企业投资收益--------
汇兑净收益--------
四、营业利润47,239,636.2425,900,215.0970,604,772.8442,223,606.22
营业外收入54,3304,2001,447,2702,890,697.91
营业外支出122,203.285,061.9965,193.2142,453.42
非流动资产处置净损失------15,453.42
五、利润总额47,171,763.0425,819,353.171,986,849.6345,071,850.71
所得税7,194,498.133,936,430.3810,317,295.526,419,541.73
未确认的投资损失--------
六、净利润(百万元)39.9821.8861.6738.65
少数股东损益--------
归属于母公司股东的净利润39,977,264.9121,882,922.7261,669,554.1138,652,308.98
七、每股收益0.50.270.860.56
基本每股收益0.50.270.860.56
稀释每股收益0.50.270.860.56
TOP↑